Navigation Links
Publication of Shire plc's Annual Report 2008
Date:3/25/2009

DUBLIN, March 25 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces that its Annual Report and Accounts in respect of the year ended December 31, 2008 has been published on its website. Shire has previously announced unaudited full year 2008 results, prepared in accordance with US generally accepted accounting principles, in its full year earnings announcement on February 19, 2009.

Copies of the Annual Report and Accounts, Notice of Annual General Meeting and Proxy Card will be submitted to the UK Listing Authority on or about March 27, 2009 and will shortly thereafter be available for inspection at the UK Listing Authority's Document Viewing Facility, which is situated at:

    Financial Services Authority
    25 The North Colonnade
    Canary Wharf
    London
    E14 5HS

    Tel: +44-(0)20-7066-1000

    Copies of the Annual Report and Accounts may also be obtained from:

    The Company Secretary's Office

    Shire plc

    Hampshire International Business Park
    Chineham, Basingstoke
    Hampshire RG24 8EP
    United Kingdom

In accordance with the requirements of Rule 4.1 of the Disclosure and Transparency Rules which applies in respect of accounting periods commencing after January 20, 2007, Appendix to this announcement contains a description of principal risks and uncertainties, business review for the year ended December 31, 2008 and the directors' responsibility statement.

    Tony Guthrie
    Deputy Company Secretary
    Notes to Editors
    SHIRE PLC

Shire's strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit hyperactivity disorder (ADHD
'/>"/>

SOURCE Shire Plc
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related biology technology :

1. Bionovo Announces Publication of Positive Phase 2 Trial Results for Menerba(TM)
2. Sopherion Therapeutics, LLC Announces Publication of Phase I/II Myocet(R) (Nonpegylated Liposomal Doxorubicin) Data in Advanced Breast Cancer Patients
3. InVitria Among Leading Innovators in Cell Culture Media According to Top Biotechnology Publication
4. BioTrends Releases TreatmentTrends(TM): US Nephrology, an Ongoing Syndicated Publication Providing Insight into Physician Perceptions and Management of Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism
5. New Publications Show Noninvasive Magnetic Resonance-Guided Focused Ultrasound to be a Potentially Safe, Effective Pain-Relieving Treatment for Bone Metastases
6. PharmSource and BioProcess Technology Consultants Announce Publication of New Market Report: Cell Culture Manufacturing Capacity: Trends and Outlook through 2013
7. Webcast Alert: Regulus Therapeutics, Alnylam Pharmaceuticals and Isis Pharmaceuticals Announce New Nature Publication on miR-21 Conference Call
8. Genomic Health Announces Publication of a Study Demonstrating the Oncotype DX(R) Breast Cancer Assay Influences Chemotherapy Treatment Recommendation in 44 Percent of Patients Evaluated
9. Publication on Tregitopes in Blood Journal of October 2008
10. Repligen Announces Publication of Positive Results with Proprietary HDAC Inhibitor in Huntingtons Disease Model
11. ABMAC Foundation Announces Publication of an Historic Volume Documenting the Creation of a National Health Care System in Taiwan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... Boston, MA (PRWEB) May 21, 2013 Possible ... parents. And so, according to a report from eagletribune.com posted ... for mold. In case the result is positive, My Cleaning ... without using harmful chemical ingredients. , It was said in ... re-infestation in the campus sparked after a first-grade ...
(Date:5/21/2013)... Clinovo's new “CDISC Standards: Theory and Application” ... June 11th, 2013. The TechTrainings are technical hands-on classes ... step in their professional career. The class will be ... online. , Taught by Sy Truong, President at Meta-Xceed ... Theory and Application” class will give an overview of ...
(Date:5/20/2013)... , May 20, 2013  MiMedx Group, Inc. (NASDAQ: ... marketer of patent protected regenerative biomaterials and bioimplants processed ... secured a revolving line of credit with Bank of ... secured by the Company,s accounts receivable and inventory, allows ... 1, 2014.  The facility will be used for general ...
(Date:5/20/2013)... Biomarkers and Clinigene International are set to unveil their ... 2013 AAPS/ National Biotechnology Conference May 20-22 ... Marina , San Diego, CA. ... company representatives at their collaborative seminar, "Biosimilarity, Immunogenicity and ... 1-2 p.m. in the conference,s Spinnaker Room. ...
Breaking Biology Technology:Possible Mold Re-infestation Gets Guilmette School Scheduled for Re-inspection, My Cleaning Products Offers Tip How to Kill Mold Safely If Inspection Turns Positive 2Possible Mold Re-infestation Gets Guilmette School Scheduled for Re-inspection, My Cleaning Products Offers Tip How to Kill Mold Safely If Inspection Turns Positive 3Clinovo Launches TechTrainings on CDISC Standards 2Pacific Biomarkers and Clinigene International To Announce Laboratory Solutions for Developers of Biosimilars at 2013 AAPS/ National Biotechnology Conference 2
... Fate Therapeutics, Inc. announced today that it has ... Chief Executive Officer.  Dr. Rastetter served as Chief Executive ... 2003, and as Chairman from May 1996 to November ... in November 2003, Dr. Rastetter served as Executive Chairman ...
... chemical sensors, researchers at the University of Illinois at ... better when the graphene is "worse"more imperfections improved performance. ... would want for transistors, for example," explained Eric Pop, ... a member of the interdisciplinary research team. "Finding that ...
... 2011 Chandler Chicco Companies (CCC), ... leading German healthcare communication firms, Haas & Health ... SanCom Creative Communication Solutions (SanCom CCS) have been ... capability in Germany. The two Eltville, ...
Cached Biology Technology:Fate Therapeutics Announces the Appointment of William H. Rastetter as Chairman of its Board of Directors and Interim CEO 2Fate Therapeutics Announces the Appointment of William H. Rastetter as Chairman of its Board of Directors and Interim CEO 3Imperfections may improve graphene sensors 2Chandler Chicco Companies Acquires Haas & Health Partner Public Relations and SanCom Creative Communication Solutions, Creating Unrivalled Healthcare Communication Capability in Germany 2Chandler Chicco Companies Acquires Haas & Health Partner Public Relations and SanCom Creative Communication Solutions, Creating Unrivalled Healthcare Communication Capability in Germany 3Chandler Chicco Companies Acquires Haas & Health Partner Public Relations and SanCom Creative Communication Solutions, Creating Unrivalled Healthcare Communication Capability in Germany 4Chandler Chicco Companies Acquires Haas & Health Partner Public Relations and SanCom Creative Communication Solutions, Creating Unrivalled Healthcare Communication Capability in Germany 5
(Date:5/21/2013)... the world,s largest scientific society, invites news media ... September 8-12, 2013, in Indianapolis, Ind. It will ... at area hotels. , With more than 7,100 ... from astronomy to zoology ― the meeting ... rich assortment of spot news and feature possibilities. ...
(Date:5/21/2013)... which alter the way genes function without changing ... in the blood of pregnant women during any ... depression in the weeks after giving birth, and ... , The findings of the small study involving ... journal Molecular Psychiatry . , "Postpartum depression ...
(Date:5/20/2013)... suggests that a compound abundant in the Mediterranean diet ... , By altering a very specific step in gene ... cells that die as scheduled. , One way that ... would cause them to die on a regular cycle ... cells, led by Ohio State University researchers, found that ...
Breaking Biology News(10 mins):Genetic predictors of postpartum depression uncovered by Hopkins researchers 2Genetic predictors of postpartum depression uncovered by Hopkins researchers 3The compound in the Mediterranean diet that makes cancer cells 'mortal' 2The compound in the Mediterranean diet that makes cancer cells 'mortal' 3
... may be at risk to higher sea levels accompanied by ... to a new study by NOAA. The study was ... the East Coast during the 2009-2010 El Nio winter. ... for Operational Oceanographic Products and Services, examined water levels and ...
... on the way antibodies distinguish between different but ... about the condition of the human body. This ... new technologies for quickly diagnosing and treating fatal ... of proteins, specifically linked to them called biomarkers. ...
... a pivotal breakthrough in the development of a cable that ... Armchair quantum wire (AQW) will be a weave of ... long distances. It will be an ideal replacement for the ... percent per 100 miles of transmission, said Rice chemist Andrew ...
Cached Biology News:Strong El Niño could bring increased sea levels, storm surges to US East Coast 2New understanding of biomarkers could lead to earlier diagnosis of fatal diseases 2New understanding of biomarkers could lead to earlier diagnosis of fatal diseases 3'Amplified' nanotubes may power the future 2'Amplified' nanotubes may power the future 3
Rabbit Anti-Human Secretory Carrier Membrane Protein 2 (SCAMP2 Polyclonal AntibodyOther Sub-Family: not assigned-Other Applications: Western Blot...
... Zeba Desalt Spin Columns contain a proprietary ... offers exceptional desalting and protein-recovery characteristics compared ... as low as 25 g/ml of protein ... and > 95% retention of salts and ...
... This immunoaffinity purified antibody detects an ~185 ... mass of ErbB-2 phosphorylated at tyrosine 1248 ... has been cross adsorbed against the non-phosphorylated ... the non-phosphorylated form of the protein. ...
Mouse Anti-Human Methyl-CpG binding domain protein 2 (MBD2 Monoclonal Antibody Family: Other Applications: Western Blot...
Biology Products: